Prudential Financial (NYSE: PRU) is scheduled to release its fourth-quarter earnings after the market closes on Tuesday, with investors closely watching for signs of resilience in the insurance sector.
Electrical systems specialist Powell Industries (NYSE:POWL) prepares to release its fourth-quarter results after Tuesday's market close, with investors weighing solid recent performance against a projected slowdown in revenue growth.
Benchmark Electronics (NYSE:BHE) is set to report Q4 earnings after Tuesday's market close, with analysts forecasting a return to revenue growth. The electronics manufacturing services provider enters the report on a strong note, having outperformed expectations last quarter.
Defense electronics specialist Mercury Systems (MRCY) is set to report quarterly results after Tuesday's close, with analysts projecting a revenue dip despite recent stock strength and positive industry tailwinds.
As Pfizer prepares to report its fourth-quarter results, investors are weighing the company's strategic pivot beyond its COVID-19 portfolio against a backdrop of expected revenue declines. The report may set the tone for the broader pharmaceutical sector.
As Transcat prepares to release its quarterly results, investors are weighing its strong revenue growth trajectory against a history of earnings volatility. The industrial distributor's performance will be a key test amid mixed signals from the sector.
Graphic Packaging Holding (NYSE:GPK) is scheduled to release its fourth-quarter earnings before Tuesday's market open. Analysts project a year-over-year revenue decline, while investor sentiment in the industrials sector shows cautious optimism.
Packaging giant Ball Corporation (NYSE: BALL) is scheduled to release its quarterly earnings before Tuesday's market open. Investors are watching for signs of sustained growth as the industry navigates shifting demand and cost pressures.
All eyes turn to Match Group as it prepares to report Q4 earnings Tuesday afternoon. With analysts forecasting modest revenue growth but lingering concerns over user attrition and profitability, investors brace for another volatile session.
As Super Micro Computer (SMCI) prepares to release its quarterly results, the market watches to see if its AI server business can sustain explosive growth and justify its soaring valuation.
While the frequency of U.S. government shutdowns has declined since the 1990s, a deepening partisan divide has transformed them into longer, more damaging stalemates, with 22 closures since 1976 imposing growing costs on federal operations and the public.
In an exclusive 'Face the Nation' interview, Nobel laureate María Corina Machado discusses Venezuela's future after U.S. intervention, while domestic debates over ICE tactics and a partial government shutdown highlight deepening political divisions.
A discounted cash flow analysis suggests shares of the Malaysian poultry and seafood firm may be overvalued at current levels, raising questions for investors.
Shares of Perspective Therapeutics (CATX) have rallied sharply following encouraging interim results from its lead cancer therapy trial and a strategic business update. While the data fuels optimism, a deep dive into the numbers reveals a stark disconnect between its current market price and analyst targets, highlighting both opportunity and significant risk.
ArcBest (ARCB) presents a complex valuation picture, with a discounted cash flow model suggesting deep undervaluation while its P/E ratio signals potential overpricing. As the stock hovers around $90, investors weigh conflicting signals against a backdrop of shifting freight demand and industry consolidation.
While Insas Berhad's (KLSE:INSAS) share price has underperformed the broader market over three years, its total shareholder return tells a different story. A closer look reveals a disconnect between stock performance and underlying business fundamentals, prompting investor scrutiny.
After a relatively subdued 2025, Wall Street's projections for Nvidia's revenue growth remain robust. Analysts are debating whether the chipmaker's current valuation sets the stage for a significant rebound or a period of consolidation.
Singapore's Venture Corporation (SGX:V03) has delivered a robust 38% total shareholder return over the past year, buoyed by dividends. However, a closer look reveals declining earnings and revenue, raising questions about the sustainability of its recent market favor and its longer-term trajectory.
As a significant equity rotation takes hold in early 2026, shifting focus from growth to value, dividend-focused ETFs are emerging as key beneficiaries for investors seeking yield and stability.
Glaukos Corporation's iDose TR glaucoma therapy receives a key FDA labeling update, permitting repeat administration. While the news bolsters the company's growth narrative, analysts are divided on whether its current stock price already reflects future potential amid rich valuation metrics.
